Hypertension-Associated Expenditures Among Privately Insured US Adults in 2021
- 1 November 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (11) , 2318-2328
Abstract
BACKGROUND: There are no recent estimates for hypertension-associated medical expenditures. This study aims to estimate hypertension-associated incremental medical expenditures among privately insured US adults. METHODS: We conducted a retrospective cohort study using IQVIA’s Ambulatory Electronic Medical Records-US data set linked with PharMetrics Plus claims data. Among privately insured adults aged 18 to 64 years, hypertension was identified as having ≥1 diagnosis code or ≥2 blood pressure measurements of ≥140/90 mm Hg, or ≥1 antihypertensive medication in 2021. Annual total expenditures (in 2021 $US) were estimated using a generalized linear model with gamma distribution and log-link function adjusting for demographic characteristics and cooccurring conditions. Out-of-pocket expenditures were estimated using a 2-part model that included logistic and generalized linear model regression. Overlap propensity score weights from logistic regression were used to obtain a balanced sample on hypertension status. RESULTS: Among the 393 018 adults, 156 556 (40%) were identified with hypertension. Compared with individuals without hypertension, those with hypertension had $2926 (95% CI, $2681–$3170) higher total expenditures and $328 (95% CI, $300–$355) higher out-of-pocket expenditures. Adults with hypertension had higher total inpatient ($3272 [95% CI, $1458–$5086]) and outpatient ($2189 [95% CI, $2009–$2369]) expenditures when compared with those without hypertension. Hypertension-associated incremental total expenditures were higher for women ($3242 [95% CI, $2915–$3569]) than for men ($2521 [95% CI, $2139–$2904]). CONCLUSIONS: Among privately insured US adults, hypertension was associated with higher medical expenditures, including higher inpatient and out-of-pocket expenditures. These findings may help assess the economic value of interventions effective in preventing hypertension.Keywords
This publication has 58 references indexed in Scilit:
- Effect of Dietary Sodium on Blood PressureJAMA, 2023
- Economic Evaluation of Blood Pressure Monitoring Techniques in Patients With HypertensionJAMA Network Open, 2023
- Body Mass Index and Associated Medical Expenditures in the US Among Privately Insured Individuals Aged 2 to 19 Years in 2018JAMA Pediatrics, 2023
- State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019JAMA Cardiology, 2023
- Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac AdmissionsJAMA Internal Medicine, 2021
- Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018JAMA, 2020
- Overlap WeightingJAMA, 2020
- US Health Care Spending by Payer and Health Condition, 1996-2016JAMA, 2020
- Sex Differences in Blood Pressure Trajectories Over the Life CourseJAMA Cardiology, 2020
- Recent Trends in Cardiovascular Mortality in the United States and Public Health GoalsJAMA Cardiology, 2016